Atyr Pharma Inc (NASDAQ: ATYR) kicked off on Friday, down -5.91% from the previous trading day, before settling in for the closing price of $0.89. Over the past 52 weeks, ATYR has traded in a range of $0.87-$7.29.
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.28%. While this was happening, its average annual earnings per share was recorded 15.75%. With a float of $95.98 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 2.05%, while institutional ownership is 67.61%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.23 earnings per share (EPS), lower than consensus estimate (set at -0.22) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.08% during the next five years compared to 34.28% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Take a look at Atyr Pharma Inc’s (ATYR) current performance indicators. Last quarter, stock had a quick ratio of 5.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Looking closely at Atyr Pharma Inc (NASDAQ: ATYR), its last 5-days average volume was 14.78 million, which is a jump from its year-to-date volume of 4.47 million. As of the previous 9 days, the stock’s Stochastic %D was 4.81%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 0.59%, which indicates a significant decrease from 0.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2631 in the past 14 days, which was lower than the 0.3928 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.4663, while its 200-day Moving Average is $4.0222. However, in the short run, Atyr Pharma Inc’s stock first resistance to watch stands at $0.8930. Second resistance stands at $0.9455. The third major resistance level sits at $0.9910. If the price goes on to break the first support level at $0.7950, it is likely to go to the next support level at $0.7495. Should the price break the second support level, the third support level stands at $0.6970.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
The company with the Market Capitalisation of 82.36 million has total of 97,987K Shares Outstanding. Its annual sales at the moment are 240 K in contrast with the sum of -64,020 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -19,530 K.
